CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Nucleus CI532 cochlear implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02671032
NCT02671032N/ACompleted
CompareCT.gov

Characterisation of Audiological Outcomes With the Nucleus CI532 Cochlear Implant in Adult Subjects.

Cochlear·interventional·Posted Feb 2, 2016·Updated Jun 9, 2021

In Brief

A clinical study evaluating Nucleus CI532 cochlear implant for Hearing Loss. Completed, enrolled 12 participants across 2 sites.

Detailed Summary

The purpose of the feasibility study is to examine audiological outcomes (audiometry and speech perception) and safety (adverse events and adverse device effects) with the Nucleus CI532 cochlear implant in group of adult subjects (n=12) who meet current criteria for cochlear implantation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesAustralia
CollaboratorsThe Hearing Cooperative Research Centre, Royal Victoria Eye and Ear Hospital

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 2, 2016
Enrollment StartJan 5, 2016
Primary CompletionJul 15, 2019
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 10.4 years ago

Interventions

Nucleus CI532 cochlear implantdevice